Physician

Abdul M Khaleq, MD

According to 2025 Medicare claims, Abdul Khaleq, MD (NPI: 1558457960) practices gastroenterology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1952327256; TIN: 941156581) and primary practice location at 95816-6006. Khaleq is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Khaleq's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 620 traditional Medicare patients, billed 1,337 HCPCS/CPT codes, and received $124,591 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,001 prescription claims across 765 beneficiaries totaling $1,143,622 in drug costs, led by Cimzia (2 Pack) (Certolizumab Pegol). Open Payments data shows 13 records totaling $906. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $2,483,333 to $1,143,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	712	1,348	$171,309
2016	734	1,416	$173,330
2017	741	1,980	$169,129
2018	733	1,912	$159,749
2019	797	1,915	$166,509
2020	586	1,343	$119,634
2021	610	1,491	$137,348
2022	601	1,375	$122,865
2023	590	1,383	$131,961
2024	620	1,337	$124,591

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	594	1,660	$2,483,333
2016	699	1,873	$2,192,572
2017	661	1,666	$863,929
2018	738	1,694	$883,677
2019	830	1,896	$930,074
2020	632	1,820	$949,225
2021	701	1,760	$667,475
2022	640	1,753	$757,441
2023	782	1,877	$967,499
2024	765	2,001	$1,143,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	190	191	$202
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	118	140	$97
45380	Biopsy of large bowel using a flexible endoscope	190	190	$86
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	165	167	$69
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	309	312	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cimzia (2 Pack)	Certolizumab Pegol	15	420	$163,775
Creon	Lipase/Protease/Amylase	42	1,662	$115,751
Humira Pen	Adalimumab	13	364	$88,550
Mesalamine	Mesalamine	111	5,747	$55,981
Linzess	Linaclotide	82	3,180	$55,105

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$906	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul M. Khaleq, MD?

Tedicare shows public-source Medicare data for Abdul M. Khaleq, MD (NPI 1558457960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul M. Khaleq, MD have ACO affiliation data?

Abdul M. Khaleq, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Abdul M. Khaleq, MD?

Abdul M. Khaleq, MD is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1952327256) in the available physician profile data.

Does Abdul M. Khaleq, MD have Open Payments data?

Abdul M. Khaleq, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.